Higher order organization of human placental aromatase

Steroids

Volumn 76, Issue 8, 2011, Pages 753-758

  Ghosh, Debashis ^a   Jiang, Wenhua ^a   Lo, Jessica ^a   Egbuta, Chinaza ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Androgen; Aromatase; Crystal structure; Estrogen; Oligomer

Indexed keywords

ANDROSTENEDIONE; AROMATASE; CYTOCHROME P450 REDUCTASE; HEME;

AMINO ACID SEQUENCE; CONFERENCE PAPER; CRYSTAL STRUCTURE; ELECTRIC POTENTIAL; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; HUMAN; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR INTERACTION; PLACENTA; PROTEIN PROTEIN INTERACTION; STATIC ELECTRICITY;

AMINO ACID SEQUENCE; ANDROGENS; ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITORS; CRYSTALLOGRAPHY, X-RAY; ESTROGENS; FEMALE; HEME; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PLACENTA; PREGNANCY; PROTEIN STRUCTURE, SECONDARY; SUBSTRATE SPECIFICITY;

EID: 79958766162     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.02.030     Document Type: Conference Paper

References (23)

1. Thompson EA, Siiteri PK. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J Biol Chem 1974;249:5364-72.
2. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 1994;15:342-55. (Pubitemid 24180792)
3. O'Neal JJ. Aromatase inhibitors. Crit Rev Biochem Mol Biol 1998;33:375-405.
4. Shimozawa O, Sakaguchi M, Ogawa H, Harada N, Mihara K, Omura T. Core glycosylation of cytochrome P-450(arom). Evidence for localization of N terminus of microsomal cytochrome P-450 in the lumen. J Biol Chem 1993;268:21399-402. (Pubitemid 23292334)
5. Amarneh B, Corbin CJ, Peterson JA, Simpson ER, Graham-Lorence S. Functional domains of human aromatase cytochrome P450 characterized by linear alignment and site-directed mutagenesis. Mol Endocrinol 1993;7:1617-24. (Pubitemid 24034244)
6. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011;32:81-151.
7. Montemurro F, Aglietta M. Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy. Endocr Relat Cancer 2009;16:1091-102.
8. Brueggemeier RW. Update on the use of aromatase inhibitors in breast cancer. Expert Opin Pharmacother 2006;7:1919-30. (Pubitemid 44489366)
9. Eisen A, Trudeau M, Shelley W, Messersmith H, Pritchard KI. Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review. Cancer Treat Rev 2008;34:157-74.
10. Santen RJ, Brodie H, Simpson ER, Siiteri PK, Brodie A. History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev 2009;30:343-75.
11. Ghosh D, Griswold J, Erman M, Pangborn W. Structural basis for androgen specificity and oestrogen biosynthesis in human aromatase. Nature 2009;457:219-23.
12. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res 2000;28:235-42. (Pubitemid 30047768)
13. Lala P, Higashiyama T, Erman M, Griswold J, Wagner T, Osawa Y, et al. Suppression of human cytochrome P450 aromatase activity by monoclonal and recombinant antibody fragments and identification of their stable antigenic complex. J Steroid Biochem Mol Biol 2004;88:235-45. (Pubitemid 38559072)
14. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr Sect D: Biol Crystallogr 2004;60:2126-32. (Pubitemid 41742764)
15. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera: a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605-12.
16. Molecular Operating Environment (MOE), version 2009.10. Montreal, Quebec, Canada: Chemical Computing Group, Inc.; 2009.
17. Praporski S, Ng SM, Nguyen AD, Corbin CJ, Mechler A, Zheng J, et al. Organization of cytochrome P450 enzymes involved in sex steroid synthesis: protein-protein interaction in lipid membranes. J Biol Chem 2009;284:33224-32.
18. Hong Y, Li H, Yuan Y, Chen S. Molecular characterization of aromatase. Ann N Y Acad Sci 2009;1155:112-20.
19. Tosha T, Yoshioka S, Hori H, Takahashi S, Ishimori K, Morishima I. Molecular mechanism of the electron transfer reaction in cytochrome P450(cam)-putidaredoxin: roles of glutamine 360 at the heme proximal site. Biochemistry 2002;41:13883-93. (Pubitemid 35364862)
20. Unno M, Shimada H, Toba Y, Makino R, Ishimura Y. Role of Arg112 of cytochrome P450cam in the electron transfer from reduced putidaredoxin: analyses with site-directed mutants. J Biol Chem 1996;271:17869-74. (Pubitemid 26250765)
21. Sevrioukova IF, Li H, Zhang H, Peterson JA, Poulos TL. Structure of a cytochrome P450-redox partner electron-transfer complex. Proc Natl Acad Sci U S A 1999;96:1863-8. (Pubitemid 29117833)
22. Hong Y, Li H, Ye J, Miki Y, Yuan YC, Sasano H, et al. Epitope characterization of an aromatase monoclonal antibody suitable for the assessment of intratumoral aromatase activity. PLoS One 2009;30:e8050.
23. Catalano S, Barone I, Giordano C, Rizza P, Qi H, Gu G, et al. Rapid estradiol/ER signaling enhances aromatase enzymatic activity in breast cancer cells. Mol Endocrinol 2009;23:1634-45.